Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Liling Hengtai Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, and manufacturing of chemical drug products. The company operates a modern production base in Beijing that adheres to national Good Manufacturing Practice (GMP) standards. Its product portfolio primarily focuses on common therapeutic areas such as cardiovascular health, respiratory treatments, and anti-infectives. Liling Hengtai is recognized for its integrated approach to drug production, covering everything from raw material processing to finished dosage forms. The company serves the domestic Chinese market through a robust distribution network and hospital partnerships.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Liling Hengtai Pharmaceutical.